Ductal adenocarcinoma of the prostate: Clinical and biological profiles-Reference-Cited by-同舟云学术

Ductal adenocarcinoma of the prostate: Clinical and biological profiles

Published:2017-07-12 Issue:12 Volume:77 Page:1242-1250
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Vinceneux Armelle¹²,Bruyère Franck³,Haillot Olivier³,Charles Thomas⁴,de la Taille Alexandre⁵,Salomon Laurent⁵,Allory Yves⁶,Ouzaid Idir⁷,Choudat Laurence⁸,Rouprêt Morgan⁹,Comperat Eva¹⁰,Houede Nadine¹¹,Beauval Jean-Baptiste¹²^ORCID,Vourc'h Patrick¹³,Fromont Gaëlle¹²^ORCID

Affiliation:

1. Department of Pathology; CHU de tours, Université François Rabelais; Tours France

2. INSERM UMR 1069; Tours France

3. Department of Urology, CHU de Tours, Pres Centre Val de Loire; Université François Rabelais de Tours; Tours France

4. Service d'Urologie, CHU de Poitiers; Université de Poitiers; Poitiers France

5. Department of Urology, Henri Mondor Hospital; AP-HP; Créteil France

6. Department of Pathology and Tissue Biobank Unit, Henri Mondor Hospital; AP-HP; Créteil France

7. Department of Urology, Bichat-Claude Bernard Hospital; AP-HP; Paris France

8. Department of Pathology, Bichat-Claude Bernard Hospital; AP-HP; Paris France

9. Department of Urology, Pitié- Salpétrière Hospital, Assistance Publique Hôpitaux de Paris; University Pierre et Marie Curie, Paris 6; Paris France

10. Department of Pathology, Pitié-Salpétrière Hospital, Assistance Publique Hôpitaux de Paris; University Pierre et Marie Curie, Paris 6; Paris France

11. Department of Medical Oncology; Groupe Hospitalier Universitaire Caremeau; Nîmes France

12. Department of Urology, Andrology and Renal Transplantation; CHU Rangueil; Toulouse France

13. Laboratoire de Biochimie et Biologie moléculaire, CHRU de Tours, INSERM U930; Université François-Rabelais; Tours France

Funder

The Association Francaise d'Urologie (AFU)

The Cancer Patients Association CANCEN

Publisher

Wiley

Subject

Urology,Oncology

Reference31 articles.

1. Prostatic duct adenocarcinoma. Findings at radical prostatectomy;Christensen;Cancer,1991

2. Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy;Tu;Cancer,2009

3. Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the surveillance, epidemiology, and end results program;Meeks;BJU Int,2012

4. Contemporary population-based comparison of localized ductal adenocarcinoma and high-risk acinar adenocarcinoma of the prostate;Packiam;Urology,2015

5. Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens;Seipel;Virchows Arch,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of unconventional histological subtypes on magnetic resonance imaging and oncological outcomes in patients who have undergone radical prostatectomy;Scientific Reports;2024-06-27

2. Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical management;Urologic Oncology: Seminars and Original Investigations;2024-05

3. Deficiency in SPOP-mediated ubiquitination and degradation of TIAM1 promotes gastric cancer progression;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-03

4. Implications of unconventional histological subtypes on magnetic resonance imaging and oncological outcomes in patients who have undergone radical prostatectomy;2024-01-30

5. Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review;European Urology;2023-07